|
ISG20L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.57880433358105E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28794760914752E-12 |
| Normal-vs-Stage2 |
1.030990E-04 |
| Normal-vs-Stage3 |
7.867600E-02 |
| Normal-vs-Stage4 |
1.596560E-01 |
| Stage1-vs-Stage2 |
6.114400E-01 |
| Stage1-vs-Stage3 |
4.876900E-03 |
| Stage1-vs-Stage4 |
9.891600E-02 |
| Stage2-vs-Stage3 |
1.349630E-01 |
| Stage2-vs-Stage4 |
2.763600E-01 |
| Stage3-vs-Stage4 |
8.463800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33150046544017E-10 |
| Normal-vs-AfricanAmerican |
4.54060000709688E-09 |
| Normal-vs-Asian |
9.764100E-02 |
| Caucasian-vs-AfricanAmerican |
7.159600E-01 |
| Caucasian-vs-Asian |
8.797600E-01 |
| AfricanAmerican-vs-Asian |
9.579200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.71727085277007E-12 |
| Normal-vs-Female |
4.598400E-03 |
| Male-vs-Female |
3.177900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.74800000053122E-07 |
| Normal-vs-Extreme_Weight |
1.73394631985957E-12 |
| Normal-vs-Obese |
3.49399999999278E-06 |
| Normal-vs-Extreme_Obese |
1.400060E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.153400E-01 |
| Normal_Weight-vs-Obese |
3.091600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.997200E-01 |
| Extreme_Weight-vs-Obese |
1.438300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.910800E-01 |
| Obese-vs-Extreme_Obese |
2.999600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.525600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.64199995214653E-09 |
| Normal-vs-Age(61-80Yrs) |
1.05149999818366E-10 |
| Normal-vs-Age(81-100Yrs) |
3.60609986316263E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.221700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.084100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.618200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.739400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.968000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.224300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.65436586441592E-13 |
| Normal-VS-Type2 PRCC |
4.1580999998736E-07 |
| Normal-VS-KIRP CIMP |
6.501600E-01 |
| Normal-VS-Unclassified PRCC |
7.579300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.278150E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.970800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.731900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.060200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.192400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.316100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45220002689683E-09 |
| Normal-vs-N1 |
9.590200E-01 |
| Normal-vs-N2 |
5.463800E-01 |
| N0-vs-N1 |
7.024500E-03 |
| N0-vs-N2 |
1.735780E-01 |
| N1-vs-N2 |
6.524600E-01 |
|
|
